Back to mobile site

More on ELDN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Eledon Pharmaceuticals (NQ:ELDN)
Delayed: 3.02 +0.09 (3.07%)
Prev. Close $2.93  
Open$2.98 
52 Wk High$ 
52 Wk Low$ 
Day High$3.06 
Day Low$2.93 
P/E N/A  
EPS$ 
Volume1,197,883 

Friends, Peers and Foes (?): NCEL NTRA (more...)

Sep 3, 2026 07:01 AM Eledon files IND for islet cell trial, eyes Phase 3 kidney study
Sep 3, 2026 07:00 AM Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial
Aug 13, 2026 04:41 PM Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Aug 13, 2026 04:32 PM Form 10-Q Eledon Pharmaceuticals, For: Jun 30
Aug 13, 2026 04:10 PM Form 8-K Eledon Pharmaceuticals, For: Aug 13
Aug 13, 2026 04:05 PM Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 4, 2026 05:23 PM Form 4 Eledon Pharmaceuticals, For: Jul 31 Filed by: Gros David-Alexandre C
Aug 4, 2026 05:22 PM Form 4 Eledon Pharmaceuticals, For: Jul 31 Filed by: Perrin Steven
Jul 31, 2026 10:17 AM Form SCHEDULE 13G Eledon Pharmaceuticals, Filed by: VANGUARD CAPITAL MANAGEMENT LLC
Jul 21, 2026 06:31 AM Rodman & Renshaw Starts Eledon Pharamceuticals (ELDN) at Buy
View All Articles

Entities mentioned with ELDN

View All Entities